9996 — Peijia Medical Cashflow Statement
0.000.00%
- HK$1.55bn
- HK$773.33m
- CNY441.13m
Annual cashflow statement for Peijia Medical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -532 | -2,069 | -574 | -398 | -392 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 420 | 1,922 | 51.7 | -113 | -4.45 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.33 | -54.4 | 58.6 | 99.3 | -230 |
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -103 | -181 | -436 | -376 | -583 |
Capital Expenditures | -13.5 | -27.9 | -201 | -202 | -316 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 45.5 | 15.5 | -223 | -261 | -70.1 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 32 | -12.5 | -425 | -463 | -386 |
Financing Cash Flow Items | -3.94 | -6.8 | -4.07 | -2.81 | -6.01 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 476 | 2,342 | 742 | 117 | 85.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 410 | 1,954 | -162 | -626 | -874 |